Chinese English Japanese Germany Korea
ChemicalBook >제품 카탈로그 >(R)-3-(3-FLUOROPHENYL)-5-(HYDROXYMETHYL)OXAZOLIDIN-2-ONE

(R)-3-(3-FLUOROPHENYL)-5-(HYDROXYMETHYL)OXAZOLIDIN-2-ONE

(R)-3-(3-FLUOROPHENYL)-5-(HYDROXYMETHYL)OXAZOLIDIN-2-ONE 구조식 이미지
카스 번호:
149524-42-5
상품명:
(R)-3-(3-FLUOROPHENYL)-5-(HYDROXYMETHYL)OXAZOLIDIN-2-ONE
동의어(영문):
Tedizolid Impurity 33;(5R)-3-(3-Fluorophenyl)-5-hydroxymethyloxazolidin-2-one;(R)-3-(3-Fluorophenyl)-5-(hydroxymethyl)-2-oxazolidinone;(R)-3-(3-FLUOROPHENYL)-5-(HYDROXYMETHYL)OXAZOLIDIN-2-ONE;2-Oxazolidinone, 3-(3-fluorophenyl)-5-(hydroxyMethyl)-, (5R)-;(5R)-3-(3-fluorophenyl)-5-(hydroxyMethyl)-1,3-oxazolidin-2-one;Tedizolid Impurity 1: (R) -3- (3-fluorophenyl) -5-hydroxymethyloxazolidin-2-one
CBNumber:
CB5396162
분자식:
C10H10FNO3
포뮬러 무게:
211.19
MOL 파일:
149524-42-5.mol
MSDS 파일:
SDS

(R)-3-(3-FLUOROPHENYL)-5-(HYDROXYMETHYL)OXAZOLIDIN-2-ONE 속성

끓는 점
341.2±25.0 °C(Predicted)
밀도
1.368±0.06 g/cm3(Predicted)
저장 조건
2-8°C
산도 계수 (pKa)
14.05±0.10(Predicted)
안전
  • 위험 및 안전 성명
  • 위험 및 사전주의 사항 (GHS)
그림문자(GHS): GHS hazard pictograms
신호 어: Warning
유해·위험 문구:
암호 유해·위험 문구 위험 등급 범주 신호 어 그림 문자 P- 코드
H302 삼키면 유해함 급성 독성 물질 - 경구 구분 4 경고 GHS hazard pictograms P264, P270, P301+P312, P330, P501
H315 피부에 자극을 일으킴 피부부식성 또는 자극성물질 구분 2 경고 GHS hazard pictograms P264, P280, P302+P352, P321,P332+P313, P362
H319 눈에 심한 자극을 일으킴 심한 눈 손상 또는 자극성 물질 구분 2A 경고 GHS hazard pictograms P264, P280, P305+P351+P338,P337+P313P
H332 흡입하면 유해함 급성 독성 물질 흡입 구분 4 경고 GHS hazard pictograms P261, P271, P304+P340, P312
H335 호흡 자극성을 일으킬 수 있음 특정 표적장기 독성 - 1회 노출;호흡기계 자극 구분 3 경고 GHS hazard pictograms
예방조치문구:
P261 분진·흄·가스·미스트·증기·...·스프레이의 흡입을 피하시오.
P280 보호장갑/보호의/보안경/안면보호구를 착용하시오.
P305+P351+P338 눈에 묻으면 몇 분간 물로 조심해서 씻으시오. 가능하면 콘택트렌즈를 제거하시오. 계속 씻으시오.

(R)-3-(3-FLUOROPHENYL)-5-(HYDROXYMETHYL)OXAZOLIDIN-2-ONE C화학적 특성, 용도, 생산

(R)-3-(3-FLUOROPHENYL)-5-(HYDROXYMETHYL)OXAZOLIDIN-2-ONE 준비 용품 및 원자재

원자재

준비 용품

Torezolid (S)-N-[3-(3-FLUORO-4-IODO-PHENYL)-2-OXO-OXAZOLIDIN-5-YLMETHYL]-ACETAMIDE (5R)-3-(4-BROMO-3-FLUOROPHENYL)-5-HYDROXYMETHYLOXAZOLIDIN-2-ONE

(R)-3-(3-FLUOROPHENYL)-5-(HYDROXYMETHYL)OXAZOLIDIN-2-ONE 공급 업체

글로벌( 87)공급 업체
공급자 전화 이메일 국가 제품 수 이점
Capot Chemical Co.,Ltd. 		571-85586718 +8613336195806
 sales@capotchem.com China 29797 60
Alchem Pharmtech,Inc. 		8485655694
sales@alchempharmtech.com United States 63711 58
CONIER CHEM AND PHARMA LIMITED 		+8618523575427
 sales@conier.com China 47465 58
career henan chemical co 		+86-0371-86658258 15093356674;
 factory@coreychem.com China 29826 58
Fuxin Pharmaceutical 		+86-021-021-50872116 +8613122107989
 contact@fuxinpharm.com China 10297 58
AFINE CHEMICALS LIMITED 		0571-85134551
info@afinechem.com CHINA 15377 58
Baoji Guokang Healthchem co.,ltd 		+8615604608665 15604608665
 dominicguo@gk-bio.com CHINA 9427 58
Hangzhou Huarong Pharm Co., Ltd. 		571-86758373 +8613588754946
 sales@huarongpharm.com CHINA 3149 58
Labnetwork lnc. 		+86-27-50766799 +8618062016861
 contact@labnetwork.com China 19994 58
AstaTech(Chengdu) Biopharmaceutical Corp. 		+86-02882666559 +86-15884417729
 gjpu@astatech.com.cn China 308 58

(R)-3-(3-FLUOROPHENYL)-5-(HYDROXYMETHYL)OXAZOLIDIN-2-ONE 관련 검색:

bis(((R)-3-(3-fluoro-4-(6-(2-methyl-2H-tetrazol-5-yl)pyridin-3-yl)phenyl)-2-oxooxazolidin-5-yl)methyl) hydrogen phosphate Tedizolid Impurity 32 Tedizolid Impurity 36 (S)-3-(4-bromo-3-fluorophenyl)-5-(hydroxymethyl)oxazolidin-2-one Tedizolid IMpurity Tedizolid Impurity 39 (S)-(+)-Glycidyl butyrate Tedizolid Impurity 36 Torezolid 2-(1-methyltetrazol-5-yl)pyridine (R)-(3-(3-fluoro-4-(6-(2-methyl-2H-tetrazol-5-yl)pyridin-3-yl) phenyl)-2-oxooxazolidin-5-yl)methyl butyrate (R)-Glycidyl butyrate (R)-3-(4-(6-(1H-tetrazol-5-yl)pyridin-3-yl)-3-fluorophenyl)-5-(hydroxymethyl)oxazolidin-2-one Tedizolid phosphate impurity 5-Bromo-2-pyridinecarbonitrile ((R)-3-(3-fluoro-4-(6-(2-methyl-2H-tetrazol-5-yl)pyridin-3-yl)phenyl)-2-oxooxazolidin-5-yl)methyl trihydrogen diphosphate 6,6'-bis(2-methyl-2H-tetrazol-5-yl)-3,3'-bipyridine (R)-5-(2-fluoro-4-(5-(hydroxymethyl)-2-oxooxazolidin-3-yl) phenyl)-2-(2-methyl-2H-tetrazol-5-yl)pyridine 1-oxide
Copyright 2019 © ChemicalBook. All rights reserved